Global wound care leader Dr. Thomas Serena joins Untech Advisory Board

Untech announced that Dr. Thomas Serena, one of the world’s leading experts in chronic wounds, has joined its Advisory Board. Dr. Serena is a globally recognized key opinion leader (KOL) in wound care, founder of the SerenaGroup and a principal investigator in numerous multicenter clinical trials focused on chronic wound healing. His research has contributed to studies involving hundreds of patients across multiple sites, advancing evidence-based treatment approaches in areas such as diabetic foot ulcers and infection management (PubMed).

Widely regarded as a pioneer in the field, Dr. Serena’s expertise in clinical development and translational research strengthens Untech’s path toward global validation and commercialization. His addition reinforces the company’s commitment to bringing a new therapeutic paradigm to the treatment of chronic wounds.